Integra Lifesciences Holdings (IART) Operating Income Growth (1y) (2010 - 2026)
Integra Lifesciences Holdings (IART) Operating Income Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 16.18% |
| 10 | Integra Lifesciences Holdings | 1.29 Bn | 1.02 Bn | 219.74 Mn | 103.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 103.76% |
| Mar 31, 2026 | 174.01% |
| Dec 31, 2025 | -35.33% |
| Sep 30, 2025 | 244.31% |
| Jun 30, 2025 | -16,825.52% |
| Mar 31, 2025 | -490.94% |
| Dec 31, 2024 | -1.17% |
| Sep 30, 2024 | -130.65% |
| Jun 30, 2024 | -124.22% |
| Mar 31, 2024 | -89.10% |
| Dec 31, 2023 | -46.86% |
| Sep 30, 2023 | -59.12% |
| Jun 30, 2023 | -79.11% |
| Mar 31, 2023 | -21.19% |
| Dec 31, 2022 | 16.52% |
| Sep 30, 2022 | 15.26% |
| Jun 30, 2022 | 15.45% |
| Mar 31, 2022 | 50.30% |
| Dec 31, 2021 | 10.60% |
| Sep 30, 2021 | -1.92% |